HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week ...
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
TipRanks on MSN22h
Fresenius Medical Care Secures €1.1 Billion Through Bond IssuanceFresenius Medical Care ( ($FMS) ) has shared an announcement. On April 1, 2025, Fresenius Medical Care successfully placed bonds totaling €1.1 ...
A PharmaSphere Inc. subsidiary didn’t mislead the US Patent and Trademark Office to obtain the patent at the center of an ...
Fresenius, Danone and Proximus benchmarks shake off tariff turmoil â—† Range of new issue concessions needed â—† High orderbook attrition for those pushing hard on spread ...
The primary driver behind last 12 months revenue was the Fresenius Helios segment contributing a total revenue of €12.7b (58% ...
With this in mind, we will now have a look at the 8 Most Undervalued Healthcare Stocks To Buy According To Analysts. For our ...
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
But Trump has already promised a 25% tariff on cars and parts and 25% on steel and aluminium, sending bond spreads for companies in those sectors wider. Wednesday was supposed to bring clarity after ...
On March 26, 2025, the FDA approved Fresenius Kabi’s denosumab biosimilars, CONEXXENCE® (denosumab-bnht) and BOMYNTRA® (denosumab-bnht), ...
During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...
Originally approved by the FDA in September 2023, Biogen's Tofidence became the first tocilizumab biosimilar available in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback